The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice
Open accessAbstract
Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 11beta-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11beta-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) in adipose tissue results in a mouse with abdominal obesity that develops hypertension (225).”
From Cardiac remodeling in obesity (2008) · cites this paper as [225]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Self-citationA transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Self-citationO'Brien, E. T., Sheridan, J., & O'MALLEY, K. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92867-x · Cited by 1,032
Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. N., Houston, P., Schmoll, D., Jamieson, P. M., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 863
Self-citationDefinitions and characteristics of sodium sensitivity and blood pressure resistance.
Weinberger, M. H., Miller, J. Z., Luft, F. C., Grim, C. E., & Fineberg, N. S. (1986) · Hypertension · doi:10.1161/01.hyp.8.6_pt_2.ii127 · Cited by 775
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 741
Self-citationThe perils of portliness: causes and consequences of visceral adiposity.
Montague, C. T., & O’Rahilly, S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.883 · Cited by 735
Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E., Olsson, T., Söderberg, S., Andrew, R., Livingstone, D. E. W., Johnson, O., & Walker, B. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7453 · Cited by 657
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07793.x · Cited by 599
Björntorp, P. A., & Rosmond, R. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00422-6 · Cited by 584
Yamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J., Lopez, M. E., Hollenberg, A., Baggio, L., Saper, C., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15595 · Cited by 544
Self-citationRenal injury from angiotensin II-mediated hypertension.
Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D. M., Pritzl, P., Floege, J., & Schwartz, S. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.464 · Cited by 534
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation
Massiéra, F., Bloch-Faure, M., Ceiler, D. L., Murakami, K., Fukamizu, A., Gasc, J., Quignard‐Boulangé, A., Négrel, R., Ailhaud, G. P., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505
Pathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477
Self-citationMorton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 444
Self-citationYamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429
Self-citationRask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Livingstone, D. E. W., Jones, G. C., Smith, K., Jamieson, P. M., Andrew, R., Kenyon, C. J., & Walker, B. R. (2000) · Endocrinology · doi:10.1210/endo.141.2.7297 · Cited by 354
Diep, Q. N., Mabrouk, M. E., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 343
Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats
Henriksen, E. J., Jacob, S., Kinnick, T. R., Teachey, M. K., & Krekler, M. (2001) · Hypertension · doi:10.1161/hy1101.092970 · Cited by 293
Walker, W. G., Whelton, P. K., Saito, H., Russell, R. P., & Hermann, J. (1979) · Hypertension · doi:10.1161/01.hyp.1.3.287 · Cited by 292
Butz, G. M., & Davisson, R. L. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.2.89 · Cited by 282
Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
Kotelevtsev, Y. V., Brown, R. W., Fleming, S., Kenyon, C. J., Edwards, C. R. W., Seckl, J. R., & Mullins, J. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4445 · Cited by 278
Self-citationAngiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling
Ogihara, T., Asano, T., Ando, K., Chiba, Y., Sakoda, H., Anai, M., Shojima, N., Ono, H., Onishi, Y., Fujishiro, M., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000040262.48405.a8 · Cited by 275
Paulmyer‐Lacroix, O., Boullu, S., Oliver, C., Alessi, M., & Grino, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8614 · Cited by 246
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue.
Frederich, R. C., Kahn, B. B., Peach, M. J., & Flier, J. S. (1992) · Hypertension · doi:10.1161/01.hyp.19.4.339 · Cited by 244
Self-citationThe renin-angiotensin system and natriuretic peptides in obesity-associated hypertension
Engeli, S., & Sharma, A. M. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000144 · Cited by 225
Molecular Basis of Salt Sensitivity in Human Hypertension
Poch, E., González, D., Galvañ, V. G., Bragulat, E., Coca, A., & de la Sierra, A. (2001) · Hypertension · doi:10.1161/hy1101.099479 · Cited by 202
Concordance of Murine Quantitative Trait Loci for Salt-Induced Hypertension with Rat and Human Loci
Sugiyama, F., Churchill, G. A., Higgins, D., Johns, C. A., Makaritsis, K. P., Gavras, H. P., & Paigen, B. J. (2001) · Genomics · doi:10.1006/geno.2000.6401 · Cited by 198
Pathways from obesity to hypertension: from the perspective of a vicious triangle
Montani, J.-P., Antic, V., Yang, Z., & Dulloo, A. G. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802125 · Cited by 189
Whorwood, C. B., Donovan, S. J., Flanagan, D., Phillips, D. I. W., & Byrne, C. D. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1066 · Cited by 185
Peeke, P. M., & Chrousos, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44719.x · Cited by 179
Increased Adipose Angiotensinogen Gene Expression in Human Obesity
van Harmelen, V., Ariapart, P., Hoffstedt, J., Lundkvist, I., Bringman, S., & Arner, P. (2000) · Obesity Research · doi:10.1038/oby.2000.40 · Cited by 172
Seckl, J. R. (2001) · Endocrinology · doi:10.1210/en.142.4.1371 · Cited by 172
Self-citationLlorens‐Cortés, C., Greenberg, B., Huang, H., & Corvol, P. L. (1994) · Hypertension · doi:10.1161/01.hyp.24.5.538 · Cited by 168
Bassett, M., Zhang, Y., Clyne, C., White, P., & Rainey, W. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280125 · Cited by 146
A Mouse Model for Liddle's Syndrome
Pradervand, S., Wang, Q., Burnier, M., Beermann, F., Horisberger, J. D., Hümmler, E., & Rossier, B. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122527 · Cited by 144
Crosstalk between insulin and angiotensin II signalling systems
Folli, F. B., Saad, M. J. A., Velloso, L. A., Hansen, H. F., Carandente, O., Feener, E. P., & Kahn, C. R. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212088 · Cited by 139
Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice
Williams, T. D., Chambers, J. B., Henderson, R. P., Rashotte, M. E., & Overton, J. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00612.2001 · Cited by 132
Rask, E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3330 · Cited by 126
Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases
Sandeep, T. C., & Walker, B. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00499-4 · Cited by 120
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats
Stepp, D. W., & Frisbee, J. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00695.2001 · Cited by 116
van Harmelen, V, Elizalde, M., Ariapart, P., Bergstedt-Lindqvist, S., Reynisdottir, S., Hoffstedt, J., Lundkvist, I., Bringman, S., & Arner, P. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801217 · Cited by 114
Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells
Aubert, J., Darimont, C., SAFONOVA, I., Ailhaud, G. P., & Négrel, R. (1997) · Biochemical Journal · doi:10.1042/bj3280701 · Cited by 96
Rotimi, C. N., Cooper, R., Ogunbiyi, O. J., Morrison, L. C., Ladipo, M. M., Tewksbury, D. A., & Ward, R. H. (1997) · Circulation · doi:10.1161/01.cir.95.10.2348 · Cited by 93
Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus
Mills, E., Kuhn, C. M., Feinglos, M. N., & Surwit, R. S. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.1.r73 · Cited by 89
FAMILIAL RESEMBLANCE IN THE BLOOD PRESSURE RESPONSE TO SODIUM RESTRICTION
Miller, J. Z., Weinberger, M. H., Christian, J. C., & Daugherty, S. A. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114719 · Cited by 89
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 88
Self-citationTomlinson, J., Draper, N., Mackie, J., Johnson, A. P., Holder, G., Wood, P. J., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8189 · Cited by 81
Hadoke, P. W. F., Christy, C., Kotelevtsev, Y. V., Williams, B. C., Kenyon, C. J., Seckl, J. R., Mullins, J. J., & Walker, B. R. (2001) · Circulation · doi:10.1161/hc4801.100077 · Cited by 79
Self-citationMorton, J. J., & Wallace, E. C. H. (1983) · Clinical Science · doi:10.1042/cs0640359 · Cited by 78
Visceral obesity and the metabolic syndrome: effects of weight loss.
Busetto, L. (2001) · PubMed · Cited by 76
Genetic and nongenetic determinants of salt sensitivity and blood pressure
Aw, C. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.587s · Cited by 72
ANGIOTENSIN RECEPTORS: MOLECULAR BIOLOGY AND SIGNALLING
Inagami, T., Kambayashi, Y., Ichiki, T., Tsuzuki, S., Eguchi, S., & Yamakawa, T. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03086.x · Cited by 72
Paulmyer-Lacroix, O. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2701 · Cited by 72
Angiotensinogen in Essential Hypertension
Lalouel, J.-M., Rohrwasser, A., Terreros, D. A., Morgan, T. K., & Ward, K. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123606 · Cited by 64
de la Sierra, A., Lluch, M. D. M., Coca, A., Aguilera, M. T., Galvañ, V. G., Bragulat, E., & Urbano-Márquez, A. (1996) · Clinical Science · doi:10.1042/cs0910155 · Cited by 58
Skeletal Muscle Glucocorticoid Receptor Density and Insulin Resistance
Reynolds, R. M., Chapman, K. E., Seckl, J. R., Walker, B. R., McKeigue, P., & Lithell, H. O. (2002) · JAMA · doi:10.1001/jama.287.19.2505 · Cited by 56
Self-citationEarly morning surge in blood pressure
Shimada, K., Kario, K., Umeda, Y., Hoshide, S., Hoshide, Y., & Eguchi, K. (2001) · Blood Pressure Monitoring · doi:10.1097/00126097-200112000-00015 · Cited by 53
Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study
Redón, J., Roca‐Cusachs, À., & Mora‐Macía, J. (2002) · Blood Pressure Monitoring · doi:10.1097/00126097-200204000-00004 · Cited by 53
Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension
Engeli, S., & Sharma, A. M. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200207000-00006 · Cited by 50
Angiotensinogen, adipocyte differentiation and fat mass enlargement
Ailhaud, G. P., Teboul, M., & Massiéra, F. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00006 · Cited by 44
Regulation of Very-Low-Density Lipoprotein Receptor in Hypertrophic Rat Heart
Masuzaki, H., Jingami, H., Matsuoka, N., Nakagawa, O., Ogawa, Y., Mizuno, M., Yoshimasa, Y., Yamamoto, T. T., & Nakao, K. (1996) · Circulation Research · doi:10.1161/01.res.78.1.8 · Cited by 43
Self-citationKatovich, M. J., Reaves, P. Y., Francis, S., Pachori, A. S., Wang, H., & Raizada, M. K. (2001) · Journal of Hypertension · doi:10.1097/00004872-200109000-00006 · Cited by 42
Dietary obesity and weight cycling: effects on blood pressure and heart rate in rats
Contreras, R. J., & Williams, V. L. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.6.r1209 · Cited by 35
Hodge, G., Ye, V. Z. C., & Duggan, K. A. (2002) · Experimental Physiology · doi:10.1113/eph8702322 · Cited by 28
Velliquette, R. A., Koletsky, R. J., & Ernsberger, P. R. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700303 · Cited by 25
Ebisu, H., Nishikawa, M., Tanaka, M., Okazoe, T., Morizawa, Y., Shinyama, H., & Nakamura, N. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199910000-00008 · Cited by 24
Self-citationVisceral Obesity and the Metabolic Syndrome
Rosmond, R. (2001) · Wiley eBooks · doi:10.1002/0470846739.ch23 · Cited by 21
Pratt, J. H., Ambrosius, W. T., Tewksbury, D. A., Wagner, M. A., Zhou, L., & Hanna, M. P. (1998) · Hypertension · doi:10.1161/01.hyp.32.5.875 · Cited by 18
Flagged first, then by citations
1 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Busetto, 2001, Nutr. Metab. Cardiovasc. Dis., 11, 195
- 10.1210/er.21.6.697 · DOI · Paper page
- 10.1210/jc.87.1.57 · DOI
- 10.1001/jama.267.9.1244 · DOI · Paper page
- 10.1210/jc.86.3.1418 · DOI
- 10.1210/en.141.2.560 · DOI
- Weinburger, 1986, Hypertension., 8(Suppl. II), II127
- Mills, 1993, Am. J. Physiol., 264, R73
- Contreras, 1989, Am. J. Physiol., 256, R1209
Cited by
Sorted by citations
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Self-citationHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Seravalle, G., & Grassi, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.013 · Cited by 909
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Self-citation
Metadata
- Authors
- Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- University of Dundee (GB)
- Corresponding author
- Flier, Jeffrey S.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 83-90
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC162290
- OpenAlex
- W2127764698
- Cited by
- 434
- References
- 76
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 10 · 2018: 4 · 2017: 20 · 2016: 17 · 2015: 20 · 2014: 16 · 2013: 30 · 2012: 21
- FWCI
- 26.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Eli Lilly and Company
- Wellcome Trust
- National Institutes of Health (5r01dk059751-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK056116, DK56116, DK 59751)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, adipose tissue, hypertension, salt-sensitive hypertension, renin-angiotensin system, angiotensin II, aldosterone, metabolic syndrome, obesity, transgenic mice
- MeSH terms
- Adipose Tissue, Animals, Glucocorticoids, Hydroxysteroid Dehydrogenases, Hypertension, Kidney, Male, Mice, Transgenic, Renin-Angiotensin System, Sodium Chloride, 11-beta-Hydroxysteroid Dehydrogenases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
